Chong Kun Dang Bio rises 11.14% amid COVID-19 (Nafamostat) theme surge

On the 14th, the COVID-19 (Nafamostat) theme showed strength by rising 3.50% compared to the previous day, while Jongkundang Bio, a related stock drawing attention, surged 11.14% compared to the previous day. Jongkundang Bio is known as a manufacturer of raw pharmaceutical ingredients, mainly exporting antibiotic raw materials.

[Graph] Major stock price changes in the COVID-19 (Nafamostat) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Jongkundang Bio ranked 3rd out of 13 stocks in the quant financial ranking by exceeding the theme's average scores in growth, stability, and profitability. This can be interpreted as Jongkundang Bio having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.